Abstract
Purpose
No optimal, well designed and reproducible animal model for upper urothelial carcinogenesis exists. This study characterized the histopathological features on top of immunolocalization of alpha-dystroglycans (α-DG) and matrix metalloproteinase (MMP-9) and cell turn-over in the upper urinary tract using a novel experimental model.
Methods
Seventy-five female Fischer 344 rats were divided into three groups: the control group received a 0.30-ml dose of 0.9% physiological saline; the MNU group (chemical carcinogen N-methyl-N-nitrosourea) received 0.30 ml of MNU; and the MNU-citrate group received 0.30 ml of MNU plus sodium citrate, every one intravesically every other week for a total of 4 doses. After 15 weeks, bladder, ureters and renal pelvis were collected for morphological and molecular analysis.
Results
Associated management with MNU and sodium citrate was able to lead to 100% of both urinary bladder and upper urinary tract tumors, being the high-grade noninvasive papillary urothelial carcinoma the most frequent lesion. The upper urothelium showed reduced α-DG and increased MMP-9 and Ki-67 immunoreactivities in the MNU-citrate group in relation to the other groups. MNU group presented no upper urothelium tumor and 100% bladder tumor.
Conclusions
This is a relevant evolution on experimental animal model for upper urinary tract carcinogenesis field. MMP-dependent disruption of the DG complex plays an important role in urothelial tumor carcinogenesis and showed the model applicability and significance. MNU-citrate model could contribute to a better understanding of human upper urothelial cancer development as well as to its local treatment strategies in a near future.
Similar content being viewed by others
References
Crallan RA, Georgopoulos NT, Sothgate J (2006) Experimental models of human bladder carcinogenesis. Carcinogenesis 27:374–381
Hicks RM, Wakefield JS (1972) Rapid induction of bladder cancer in rats with N-methyl-N-nitrosourea. Histology Chem Biol Interact 5:139–152
Steinberg GD, Brendler CB, Squire RA (1991) Experimental intravesical therapy for superficial transitional cell carcinoma in a rat bladder tumor model. J Urol 145:647–653
Kunze E, Graewe T, Scherber S (1989) Cell cycle dependence of N-methyl-N-nitrosourea-induced tumour development in the proliferating, partially resected rat urinary bladder. Br J Exp Pathol 70:125–142
Reis LO, Pereira TC, Fávaro WJ, Cagnon VHA, Lopes-Cendes I, Ferreira U (2009) Experimental animal model and RNA interference: a promising association for bladder cancer research. World J Urol 27:353–361
Gupta R, Paner GP, Amin MB (2008) Neoplasms of the upper urinary tract: a review with focus on urothelial carcinoma of the pelvicalyceal system and aspects related to its diagnosis and reporting. Adv Anat Pathol 15:127–139
Gen H, Yamamoto S, Morimura K, Min W, Mitsuhashi M, Murai T, Mori S, Hosono M, Oohara T, Makino S, Wanibuchi H, Fukushima S (2001) p53 and H-ras mutations and microsatellite instability in renal pelvic carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine: different genetic alteration from urinary bladder carcinoma. Jpn J Cancer Res 92:1278–1283
Petersen OW, Ronnov JL, Howlett AR, Bissell MJ (1992) Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 89:9064–9068
Brennan P, Jing J, Ethunandan M, Gorecki D (2004) Dystroglycan complex in cancer. Eur J Surg Oncol 30:589–592
Kamijima S, Tobe T, Suyama T, Ueda T, Igarashi T, Ichikawa T, Ito H (2005) The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 12:941–947
Epstein JI, Amin MB, Reuter VR, Mostofi FK (1998) Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22:1435–1448
Fukushima S, Thamavit W, Kurata Y, Ito N (1986) Sodium citrate: a promoter of bladder carcinogenesis. Jpn J Cancer Res 77:1–4
Ono S, Kurata Y, Shichino Y, Sano M, Fukushima S (1992) Synergism of environmental carcinogens and promoters on bladder cancer development initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine in F344 rats. Jpn J Cancer Res 83:955–963
Nunziata A, Storino AA (1982) Spontaneous neoplastic pathology in control rats—a review. Vet Hum Toxicol 24:243–247
Sohn BH, Moon HB, Kim TY, Kang HS, Bae YS, Lee KK, Kim SJ (2001) Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem J 360:31–38
Sgambato A, Migaldi M, Montanari M, Camerini A, Brancaccio A, Rossi G, Cangiano R, Losasso C, Capelli G, Trentini GP, Cittadini A (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am J Pathol 162:849–860
Cross SS, Lippitt J, Mitchell A, Hollingsbury F, Balasubramanian SP, Reed MW, Eaton C, Catto JW, Hamdy F, Winder SJ (2008) Expression of beta-dystroglycan is reduced or absent in many human carcinomas. Histopathology 53:561–566
Kabashima A, Maehara Y, Kakehi Y (2000) Clinicopathological features and over-expression of matrix metalloproteinases in intramural gastric carcinoma with lymph node metastasis. Clin Cancer Res 6:3581–3584
Yasumitu H, Miyazaki K, Umenishi F (1992) Comparison of extracellular matrix-degrading activities between 64-kDa and 90-kDa gelatinases purified in inhibitor-free forms from human schwannoma cells. J Biochem 111:74–80
Inoue K, Kamada M, Slaton JW (2002) The prognostic value of angiogenesis and metastasis related genes for progression of transitional cell carcinoma of renal pelvis and ureter. Clin Cancer Res 8:1863–1870
Moses MA, Wiederschain D, Loughlin KR, Zurakowski D, Lamb CC, Freeman MR (1998) Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58:1395–1399
Angell SK, Pruthi RS, Shortliffe LD (1998) The urodynamic relationship of renal pelvic and bladder pressures, and urinary flow rate in rats with congenital vesicoureteral reflux. J Urol 160:150–156
Burns CP, Rogengurt E (1984) Extracellular Na+ and initiation of DNA synthesis: role of intracellular pH and K+. J Cell Biol 98:1082–1089
Fukushima S, Tamano S, Shibata M, Kurata Y, Hirose M, Ito N (1988) The role of urinary pH and sodium ion concentration in the promotion stage of two-stage carcinogenesis of the rat urinary bladder. Carcinogenesis 9:1203–1206
Fukushima S, Shibata M, Shirai T, Tamano S, Ito N (1986) Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary ladder carcinogenesis in rats. Cancer Res 46:1623–1626
Oliveira PA, Colaco A, De la Cruz PLF (2006) Experimental bladder carcinogenesis-rodent models. Exp Oncol 28:2–11
Vercesi LA, Constatantinon CE (1986) Pressure evaluation of the antireflux ability of the rat ureterovesical junction. Urol Int 41:192–195
Lipsky H (1971) Bladder inflammation and vesico-ureteral reflux. Experimental animal studies. Urol Int 26:217–240
Weiss RM (1987) Effect of pathologic processes and pharmacologic interventions on ureteral function. Semin Urol 5:167–175
Anderstom C, Johansson SL, von Schultz L (1983) The influence of phenacetin or mechanical perforation on the development of renal pelvic and urinary bladder tumors in FANFT-induced urinary tract carcinogenesis. Acta Pathol Microbiol Immunol Scand Sect A 91:373–380
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reis, L.O., Fávaro, W.J., Ferreira, U. et al. Evolution on experimental animal model for upper urothelium carcinogenesis. World J Urol 28, 499–505 (2010). https://doi.org/10.1007/s00345-010-0545-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-010-0545-3